Clinical Trials Browser

Interventional × Uveal Melanoma × MAGEA3 protein, human × Clear all

NCT00254397 2019-10-16

Melanoma Vaccine With Peptides and Leuprolide

Phase 2 Completed

98 enrolled 11 charts

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

NCT00085189 2014-05-22

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma